Vitro Biopharma, Inc. Quarterly Goodwill in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Vitro Biopharma, Inc. quarterly Goodwill history and growth rate from Q3 2022 to Q2 2024.
  • Vitro Biopharma, Inc. Goodwill for the quarter ending July 31, 2024 was $3.61M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.61M $0 0% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $3.61M $0 0% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $3.61M $0 0% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $3.61M $0 0% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 $3.61M Jul 31, 2023 10-Q 2023-08-28
Q1 2023 $3.61M Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $3.61M Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $3.61M Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.